PMID- 30194517 OWN - NLM STAT- MEDLINE DCOM- 20190813 LR - 20200225 IS - 1559-1182 (Electronic) IS - 0893-7648 (Linking) VI - 56 IP - 5 DP - 2019 May TI - Early Behavioral Alterations and Increased Expression of Endogenous Retroviruses Are Inherited Across Generations in Mice Prenatally Exposed to Valproic Acid. PG - 3736-3750 LID - 10.1007/s12035-018-1328-x [doi] AB - Prenatal treatment with the antiepileptic drug valproic acid (VPA) is associated with a significant risk of somatic anomalies, neurodevelopmental delays, and 7-10x increase in the incidence of autism spectrum disorders (ASD) in children. Rodents exposed to VPA in pregnancy show birth defects, deficits in neurodevelopment, and cognitive/social anomalies resembling those of ASD children. Mechanisms of VPA neurobehavioral toxicity are still unclear but as VPA is a non-selective inhibitor of histone deacetylases, epigenetic modifications are likely involved. This study was aimed to evaluate the transgenerational impact of prenatal VPA exposure on mouse early behavioral development, studying F(1), F(2), and F(3) generations after VPA challenge on gestational day (GD) 10.5. We also analyzed in brain and in peripheral blood mononuclear cells the expression levels of different endogenous retrovirus (ERV) families, potential biomarkers of derailed brain development, since human ERVs have been implicated in the pathogenesis of neurodevelopmental disorders (NDDs) such as ASD. Somatic effects of VPA were evident only in F(1) generation and more markedly in the female sex. Across F(1) and F(2) generations, VPA delayed righting reflex, increased motor activity, and reduced ultrasonic vocalizations. The behavioral changes in F(3) are milder though in the same direction. VPA increased expression of most ERVs across the three generations in brain and blood. In utero VPA induced neurodevelopmental alterations more marked in the maternal lineage that persisted also in F(3), suggesting ERVs as possible downstream effectors of the VPA epigenetic alterations. FAU - Tartaglione, Anna Maria AU - Tartaglione AM AD - Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanita, V.le Regina Elena 299, 00161, Rome, Italy. FAU - Cipriani, Chiara AU - Cipriani C AD - Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. FAU - Chiarotti, Flavia AU - Chiarotti F AD - Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanita, V.le Regina Elena 299, 00161, Rome, Italy. FAU - Perrone, Benedetta AU - Perrone B AD - Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanita, V.le Regina Elena 299, 00161, Rome, Italy. FAU - Balestrieri, Emanuela AU - Balestrieri E AD - Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. FAU - Matteucci, Claudia AU - Matteucci C AD - Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. FAU - Sinibaldi-Vallebona, Paola AU - Sinibaldi-Vallebona P AD - Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. AD - Institute of Translational Pharmacology, National Research Council, Rome, Italy. FAU - Calamandrei, Gemma AU - Calamandrei G AUID- ORCID: 0000-0003-3762-3132 AD - Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanita, V.le Regina Elena 299, 00161, Rome, Italy. gemma.calamandrei@iss.it. FAU - Ricceri, Laura AU - Ricceri L AD - Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanita, V.le Regina Elena 299, 00161, Rome, Italy. LA - eng GR - 13/cal 508/Istituto Superiore di Sanita/ PT - Journal Article DEP - 20180907 PL - United States TA - Mol Neurobiol JT - Molecular neurobiology JID - 8900963 RN - 614OI1Z5WI (Valproic Acid) MH - Animals MH - *Behavior, Animal MH - Brain/pathology MH - Endogenous Retroviruses/*genetics MH - Female MH - Inheritance Patterns/*genetics MH - Male MH - Mice MH - Pregnancy MH - Prenatal Exposure Delayed Effects/blood/*pathology/*virology MH - Principal Component Analysis MH - Transcription, Genetic MH - Valproic Acid/*adverse effects/blood OTO - NOTNLM OT - Autism spectrum disorders OT - Maternal and paternal lineages OT - Neurodevelopment OT - Transgenerational effects EDAT- 2018/09/09 06:00 MHDA- 2019/08/14 06:00 CRDT- 2018/09/09 06:00 PHST- 2018/04/24 00:00 [received] PHST- 2018/08/22 00:00 [accepted] PHST- 2018/09/09 06:00 [pubmed] PHST- 2019/08/14 06:00 [medline] PHST- 2018/09/09 06:00 [entrez] AID - 10.1007/s12035-018-1328-x [pii] AID - 10.1007/s12035-018-1328-x [doi] PST - ppublish SO - Mol Neurobiol. 2019 May;56(5):3736-3750. doi: 10.1007/s12035-018-1328-x. Epub 2018 Sep 7.